Kenya Medical Supplies Authority Pharmaceutical Import Profile — Kenya (DGFT 2022–2026)

Name: Kenya Medical Supplies Authority Pharmaceutical Import Records from India — 2 Products, $500.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Kenya Medical Supplies Authority — Pharmaceutical Importer Profile (2026) | 2 Products, $500.0K Trade | TransData Nexus

Kenya Medical Supplies Authority

Pharmaceutical Importer · Kenya · Antiviral & HIV Medications Focus · $500.0K Total Trade · DGFT Verified

Kenya Medical Supplies Authority is a pharmaceutical importer based in Kenya with a total trade value of $500.0K across 2 products in 1 therapeutic categories. Based on 10 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Kenya Medical Supplies Authority sources from 8 verified Indian suppliers, with Ipca Laboratories Limited accounting for 27.2% of imports.

Kenya Medical Supplies Authority — Import Portfolio & Supplier Network

Kenya Medical Supplies Authority import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Kenya Medical Supplies Authority?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Ipca Laboratories Limited	$942.6K	19	27.2%
Emcure Pharmaceuticals Limited	$850.0K	17	24.5%
Mylan Laboratories Limited

What Formulations Does Kenya Medical Supplies Authority Import?

Formulation	Value	Ships
Pharmaceutical article / ods / product / item finished goods- viropil 50/300/300MG tablet 90s dolutegravir lamivudine & tenofovir	$300.0K	6
Pharmaceutical products (finished goods)	$150.0K	3
Pharmaceutical products (finished goods)- viropil 50/300/300MG tablet 90s wtc (dolutegravir, lamivudine & tenofovir	$150.0K	3
Harmless medicines: artesunate for injection 60MG(larinate-60)(344300x1x5ml=344300 injection)r.b.d: artesunate	$150.0K	3
Atazanavir 300MG + ritonavir 100MG tablets 30s (42580 packs x 30s = 1277400 nos)	$150.0K	3
Lumiter dt (artemether 20/lumefantrine 120MG dispersible tabs) 30x12s (15667 pac	$149.5K	3
Harmless medicines:artemether 20MG and lumefantrine120mg tablets(11010x30x24's Pack=7927200 tablets)r.b.d	$142.6K	3
Lumiter dt (artemether 20/lumefantrine 120MG dispersible tabs) 30x6s (18667 pac	$114.4K	3
Pharmaceutical products finished goods atazor r 300 100 MG tablet 30s atazanavir ritonavir tablets 300 100MG	$100.0K	2
Harmless medicines:artemether 20MG and	$100.0K	2
Tenofovir disoproxil fumarate 300MG + lamivudine 300MG tablets 30s packs 30s bottle67322 packs x 30s=2019660	$100.0K	2
Lamivudine 150MG + zidovudine 300MG tablets 60s packs 60s bottle 38889packs x 60s=2333340	$100.0K	2
Lamivudine 150MG + zidovudine 300MG tablets 60s packs 60s bottle39274 packs x 60s=2356440	$100.0K	2
Abacavir sulfate 600MG lamivudine 300mgtablets 30s 45728 packs x 30s 1371840	$50.0K	1
Abacavir sulfate 600MG lamivudine 300MG tablets 30s 39165 packs x 30s 1174950 00	$50.0K	1

Kenya Medical Supplies Authority imports 51 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Atazanavir	Antiviral & HIV Medications	$250.0K	5	0.4%	3
2	Ritonavir	Antiviral & HIV Medications	$250.0K	5	0.1%	11

Kenya Medical Supplies Authority imports 2 pharmaceutical products across 1 categories into Kenya totaling $500.0K.

Kenya Medical Supplies Authority — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

The Kenya Medical Supplies Authority (KEMSA) is a state corporation under the Ministry of Health, established under the KEMSA Act of 2013. Its primary mandate is to procure, warehouse, and distribute health products and technologies for public health programs, the national strategic stock reserve, essential health packages, and national referral hospitals. KEMSA operates as a specialized medical logistics provider, ensuring the efficient supply of medical commodities to public health facilities across Kenya. (kemsa.go.ke)

Headquartered in Nairobi, KEMSA has a robust logistics network that spans the entire country, serving over 10,000 facilities, including national and county government hospitals, faith-based organizations, non-governmental organizations, learning institutions, and specialized institutions such as the Kenya Defense Forces and prisons. (kemsa.go.ke) The authority plays a pivotal role in the national agenda of implementing Universal Health Coverage (UHC) by ensuring the availability of essential health products and technologies across the country. (kemsa.go.ke)

2Distribution Network

KEMSA's distribution network is extensive, encompassing a central warehouse in Nairobi and multiple regional depots strategically located to serve the 47 counties of Kenya. This network ensures timely and efficient delivery of medical supplies to health institutions nationwide. The authority's logistics capabilities include modern infrastructure such as racking systems, air conditioning, CCTV surveillance, cold-chain storage facilities, quality assurance laboratories, and modern mechanical handling equipment. (kemsa.go.ke)

In addition to domestic operations, KEMSA has demonstrated flexibility in its distribution model, extending services beyond Kenya's borders upon special requests from the Ministry of Health. This adaptability has seen the authority provide medical supplies to neighboring countries like Tanzania and South Sudan, highlighting its capacity to manage cross-border logistics effectively. (kemsa.go.ke)

3Industry Role

KEMSA functions as the primary wholesaler and distributor of medical supplies within Kenya's pharmaceutical supply chain. Its role is central to the procurement, warehousing, and distribution of health products and technologies to public health facilities, ensuring that essential medical commodities are accessible across the country. By managing the national strategic stock reserve and collaborating with county governments, KEMSA plays a crucial role in the efficient delivery of healthcare services. (kemsa.go.ke)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Kenya Medical Supplies Authority

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

KEMSA's sourcing strategy exhibits a high degree of concentration, with a total import value of $500,000 USD from India across 10 shipments, primarily consisting of two products: Atazanavir and Ritonavir, each valued at $250,000 USD. This concentration indicates a strategic focus on specific therapeutic areas, particularly antiviral and HIV medications. While such a focused approach can streamline procurement processes and potentially secure favorable terms with suppliers, it also exposes KEMSA to risks associated with supplier dependency. The reliance on a limited number of products and suppliers may lead to challenges in supply chain resilience, especially if there are disruptions in the supply of these specific medications.

The shipment data reveals a stable relationship with Indian suppliers, as evidenced by the consistent import volumes over the period. However, the lack of diversification in both product range and supplier base suggests that KEMSA may benefit from exploring additional suppliers and products to mitigate potential risks associated with over-reliance on a narrow sourcing strategy.

2Supply Chain Resilience

KEMSA's supply chain resilience concerning its Indian suppliers appears to be moderate. The authority has established relationships with several Indian pharmaceutical companies, including IPCA Laboratories Limited, Emcure Pharmaceuticals Limited, and Mylan Laboratories Limited, each contributing significantly to the total import value. However, the concentration on a limited number of products—Atazanavir and Ritonavir—suggests a potential vulnerability in the supply chain. Diversifying the product portfolio and engaging with a broader range of suppliers could enhance resilience by reducing dependency on specific products and suppliers. Additionally, exploring alternative sourcing options and establishing backup suppliers would further strengthen the supply chain against potential disruptions.

Importing Pharmaceuticals into Kenya — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Kenya

1Regulatory Authority & Framework

In Kenya, the Pharmacy and Poisons Board (PPB) serves as the primary regulatory authority overseeing the importation, distribution, and sale of pharmaceutical products. The PPB is responsible for ensuring that all medical commodities meet the required safety, efficacy, and quality standards before they are permitted for use within the country. Key legislation governing pharmaceutical imports includes the Pharmacy and Poisons Act, which outlines the procedures for registration, importation, and distribution of drugs. Additionally, the Food, Drugs and Chemical Substances Act provides further regulatory guidelines to ensure public health safety.

The marketing authorization pathway for Indian generics involves several steps:

1. Product Registration: Manufacturers must submit an application to the PPB, providing comprehensive data on the product's quality, safety, and efficacy.

2. Evaluation: The PPB evaluates the submitted data to ensure compliance with Kenyan standards.

3. Approval: Upon successful evaluation, the product is granted marketing authorization, allowing it to be imported and distributed within Kenya.

4. Post-Market Surveillance: Continuous monitoring is conducted to ensure ongoing compliance and to address any emerging safety concerns.

2Import Licensing & GMP

Kenya Medical Supplies Authority — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

KEMSA's focus on importing antiviral and HIV medications, specifically Atazanavir and Ritonavir, aligns with the high prevalence of HIV/AIDS in Kenya. This strategic emphasis ensures that essential antiretroviral therapies are readily available to public health facilities, supporting the national efforts in HIV management and treatment. The demand for these medications is driven by the need to provide continuous and effective treatment to individuals living with HIV, thereby improving health outcomes and quality of life.

2Sourcing Profile

KEMSA's sourcing strategy is centered on procuring generic drugs, particularly antiretroviral medications, from Indian manufacturers. This approach leverages the cost-effectiveness and quality of Indian generics, enabling KEMSA to provide affordable healthcare solutions to the Kenyan public. The authority's preference for specific formulations, such as Atazanavir and Ritonavir, reflects a targeted approach to meet the therapeutic needs of the population.

3Market Positioning

Based on its product mix, KEMSA serves the public health sector in Kenya, supplying essential medical commodities to government hospitals, clinics, and other healthcare facilities. Its role as a primary wholesaler and distributor positions it as a critical player in the healthcare supply chain, ensuring that public health institutions have access to necessary medications and medical supplies.

Frequently Asked Questions — Kenya Medical Supplies Authority

What products does Kenya Medical Supplies Authority import from India?

Kenya Medical Supplies Authority imports 2 pharmaceutical products across 1 categories. Top imports: Atazanavir ($250.0K), Ritonavir ($250.0K).

Who supplies pharmaceuticals to Kenya Medical Supplies Authority from India?

Kenya Medical Supplies Authority sources from 8 verified Indian suppliers. The primary supplier is Ipca Laboratories Limited (27.2% of imports, $942.6K).

What is Kenya Medical Supplies Authority's total pharmaceutical import value?

Kenya Medical Supplies Authority's total pharmaceutical import value from India is $500.0K, based on 10 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Kenya Medical Supplies Authority focus on?

Kenya Medical Supplies Authority imports across 1 categories. The largest: Antiviral & HIV Medications (100.0%).

Get Full Kenya Medical Supplies Authority Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.